156 related articles for article (PubMed ID: 37433222)
1. ALS Variants of Annexin A11's Proline-Rich Domain Impair Its S100A6-Mediated Fibril Dissolution.
Shihora A; Elias RD; Hammond JA; Ghirlando R; Deshmukh L
ACS Chem Neurosci; 2023 Aug; 14(15):2583-2589. PubMed ID: 37433222
[TBL] [Abstract][Full Text] [Related]
2. S100A6 amyloid fibril formation is calcium-modulated and enhances superoxide dismutase-1 (SOD1) aggregation.
Botelho HM; Leal SS; Cardoso I; Yanamandra K; Morozova-Roche LA; Fritz G; Gomes CM
J Biol Chem; 2012 Dec; 287(50):42233-42. PubMed ID: 23076148
[TBL] [Abstract][Full Text] [Related]
3. Mutations in the vesicular trafficking protein annexin A11 are associated with amyotrophic lateral sclerosis.
Smith BN; Topp SD; Fallini C; Shibata H; Chen HJ; Troakes C; King A; Ticozzi N; Kenna KP; Soragia-Gkazi A; Miller JW; Sato A; Dias DM; Jeon M; Vance C; Wong CH; de Majo M; Kattuah W; Mitchell JC; Scotter EL; Parkin NW; Sapp PC; Nolan M; Nestor PJ; Simpson M; Weale M; Lek M; Baas F; Vianney de Jong JM; Ten Asbroek ALMA; Redondo AG; Esteban-Pérez J; Tiloca C; Verde F; Duga S; Leigh N; Pall H; Morrison KE; Al-Chalabi A; Shaw PJ; Kirby J; Turner MR; Talbot K; Hardiman O; Glass JD; De Belleroche J; Maki M; Moss SE; Miller C; Gellera C; Ratti A; Al-Sarraj S; Brown RH; Silani V; Landers JE; Shaw CE
Sci Transl Med; 2017 May; 9(388):. PubMed ID: 28469040
[TBL] [Abstract][Full Text] [Related]
4. Proline-rich domain of human ALIX contains multiple TSG101-UEV interaction sites and forms phosphorylation-mediated reversible amyloids.
Elias RD; Ma W; Ghirlando R; Schwieters CD; Reddy VS; Deshmukh L
Proc Natl Acad Sci U S A; 2020 Sep; 117(39):24274-24284. PubMed ID: 32917811
[TBL] [Abstract][Full Text] [Related]
5. Structure of the ALS Mutation Target Annexin A11 Reveals a Stabilising N-Terminal Segment.
Lillebostad PAG; Raasakka A; Hjellbrekke SJ; Patil S; Røstbø T; Hollås H; Sakya SA; Szigetvari PD; Vedeler A; Kursula P
Biomolecules; 2020 Apr; 10(4):. PubMed ID: 32344647
[TBL] [Abstract][Full Text] [Related]
6. S100A6 overexpression within astrocytes associated with impaired axons from both ALS mouse model and human patients.
Hoyaux D; Boom A; Van den Bosch L; Belot N; Martin JJ; Heizmann CW; Kiss R; Pochet R
J Neuropathol Exp Neurol; 2002 Aug; 61(8):736-44. PubMed ID: 12152788
[TBL] [Abstract][Full Text] [Related]
7. S100A6 and Its Brain Ligands in Neurodegenerative Disorders.
Filipek A; Leśniak W
Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32492924
[TBL] [Abstract][Full Text] [Related]
8. Genetic analysis of ANXA11 variants in a Han Chinese cohort with amyotrophic lateral sclerosis in Taiwan.
Tsai PC; Liao YC; Jih KY; Soong BW; Lin KP; Lee YC
Neurobiol Aging; 2018 Dec; 72():188.e1-188.e2. PubMed ID: 30054183
[TBL] [Abstract][Full Text] [Related]
9. S100A6, a calcium- and zinc-binding protein, is overexpressed in SOD1 mutant mice, a model for amyotrophic lateral sclerosis.
Hoyaux D; Alao J; Fuchs J; Kiss R; Keller B; Heizmann CW; Pochet R; Frermann D
Biochim Biophys Acta; 2000 Dec; 1498(2-3):264-72. PubMed ID: 11108968
[TBL] [Abstract][Full Text] [Related]
10.
Nahm M; Lim SM; Kim YE; Park J; Noh MY; Lee S; Roh JE; Hwang SM; Park CK; Kim YH; Lim G; Lee J; Oh KW; Ki CS; Kim SH
Sci Transl Med; 2020 Oct; 12(566):. PubMed ID: 33087501
[TBL] [Abstract][Full Text] [Related]
11. Genetic screening of ANXA11 revealed novel mutations linked to amyotrophic lateral sclerosis.
Teyssou E; Muratet F; Amador MD; Ferrien M; Lautrette G; Machat S; Boillée S; Larmonier T; Saker S; Leguern E; Cazeneuve C; Marie Y; Guegan J; Gyorgy B; Cintas P; Meininger V; Le Forestier N; Salachas F; Couratier P; Camu W; Seilhean D; Millecamps S
Neurobiol Aging; 2021 Mar; 99():102.e11-102.e20. PubMed ID: 33218681
[TBL] [Abstract][Full Text] [Related]
12. Phase Separation and Fibrillization of Human Annexin A7 Are Mediated by Its Proline-Rich Domain.
Yu C; Nelson SL; Meisl G; Ghirlando R; Deshmukh L
Biochemistry; 2023 Nov; 62(21):3036-3040. PubMed ID: 37788367
[TBL] [Abstract][Full Text] [Related]
13. Two rare variants of the ANXA11 gene identified in Chinese patients with amyotrophic lateral sclerosis.
Liu X; Wu C; He J; Zhang N; Fan D
Neurobiol Aging; 2019 Feb; 74():235.e9-235.e12. PubMed ID: 30337194
[TBL] [Abstract][Full Text] [Related]
14. [Mutations of G38R and D40G cause amyotrophic lateral sclerosis by reducing Annexin A11 protein stability].
Liao D; Liao Q; Huang C; Bi F
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Jun; 43(6):577-582. PubMed ID: 30109997
[TBL] [Abstract][Full Text] [Related]
15. Genetic analysis of and clinical characteristics associated with ANXA11 variants in a Chinese cohort with amyotrophic lateral sclerosis.
Jiang Q; Lin J; Wei Q; Li C; Hou Y; Cao B; Zhang L; Ou R; Liu K; Yang T; Xiao Y; Shang H
Neurobiol Dis; 2022 Dec; 175():105907. PubMed ID: 36280108
[TBL] [Abstract][Full Text] [Related]
16. Structural Model of the Proline-Rich Domain of Huntingtin Exon-1 Fibrils.
Falk AS; Bravo-Arredondo JM; Varkey J; Pacheco S; Langen R; Siemer AB
Biophys J; 2020 Nov; 119(10):2019-2028. PubMed ID: 33096080
[TBL] [Abstract][Full Text] [Related]
17. Identification and characterization of a centrosomal protein, FOR20 as a novel S100A6 target.
Sakane K; Nishiguchi M; Denda M; Yamagchi F; Magari M; Kanayama N; Morishita R; Tokumitsu H
Biochem Biophys Res Commun; 2017 Sep; 491(4):980-985. PubMed ID: 28765046
[TBL] [Abstract][Full Text] [Related]
18. Blocking the interface region amongst S100A6 and RAGE V domain via S100B protein.
Sung HY; Dowarha D; Chou RH; Yu C
Biochem Biophys Res Commun; 2020 Dec; 533(3):332-337. PubMed ID: 32958253
[TBL] [Abstract][Full Text] [Related]
19. Kaplan-Meier Meets Chemical Kinetics: Intrinsic Rate of SOD1 Amyloidogenesis Decreased by Subset of ALS Mutations and Cannot Fully Explain Age of Disease Onset.
Abdolvahabi A; Shi Y; Rasouli S; Croom CM; Aliyan A; Martí AA; Shaw BF
ACS Chem Neurosci; 2017 Jun; 8(6):1378-1389. PubMed ID: 28290665
[TBL] [Abstract][Full Text] [Related]
20. Glycerolipid Headgroups Control Rate and Mechanism of Superoxide Dismutase-1 Aggregation and Accelerate Fibrillization of Slowly Aggregating Amyotrophic Lateral Sclerosis Mutants.
Rasouli S; Abdolvahabi A; Croom CM; Plewman DL; Shi Y; Shaw BF
ACS Chem Neurosci; 2018 Jul; 9(7):1743-1756. PubMed ID: 29649360
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
